Supreme Court’s Abortion Pill Call Leaves FDA in Line of Fire

The FDA faces a long road of litigation ahead in the abortion pill case that attorneys say threatens to upend the agency’s drug approval process.

The US Supreme Court on Friday blocked a Texas judge’s restrictions on the abortion pill mifepristone from taking effect, marking a temporary win for the Biden administration as it works to defend the Food and Drug Administration’s decades-old approval.

But attorneys say the agency’s fight isn’t over: The US Court of Appeals for the Fifth Circuit is scheduled to hear oral arguments in the case May 17.

The case is likely to wind up back ...